KalVista Pharmaceuticals, Inc. short interest in 2024
In 2024, KalVista Pharmaceuticals, Inc.'s disclosed short interest ran from 8.00% of shares outstanding on 12 Jan 2024 to 15.07% on 31 Dec 2024, a change of +7.07 percentage points. The year's high was 17.06% on 15 Nov 2024 and its low 7.16% on 31 Jan 2024, averaging 13.27% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 39.53 days on 31 Oct 2024. Full history: KalVista Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 8.00% (12 Jan 2024)
- End of year
- 15.07% (31 Dec 2024)
- Change
- +7.07 pp
- High
- 17.06% (15 Nov 2024)
- Low
- 7.16% (31 Jan 2024)
- Average
- 13.27%
- Highest days to cover
- 39.53 (31 Oct 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 8.00% | 6.55 | |
| 31 Jan 2024 | 7.16% | 5.42 | |
| 15 Feb 2024 | 8.66% | 1.90 | |
| 29 Feb 2024 | 10.68% | 4.22 | results (8-K) |
| 15 Mar 2024 | 11.66% | 7.65 | 10-Q filed, results (8-K) |
| 28 Mar 2024 | 13.09% | 9.14 | |
| 15 Apr 2024 | 13.80% | 11.99 | |
| 30 Apr 2024 | 13.13% | 17.06 | |
| 15 May 2024 | 13.65% | 22.92 | |
| 31 May 2024 | 13.09% | 17.11 | |
| 14 Jun 2024 | 13.36% | 24.05 | |
| 28 Jun 2024 | 13.76% | 10.61 | |
| 15 Jul 2024 | 14.81% | 16.50 | 10-K filed, results (8-K) |
| 31 Jul 2024 | 14.00% | 19.73 | |
| 15 Aug 2024 | 13.28% | 32.13 | |
| 30 Aug 2024 | 13.06% | 18.98 | |
| 13 Sep 2024 | 13.23% | 16.84 | 10-Q filed, results (8-K) |
| 30 Sep 2024 | 15.06% | 9.86 | |
| 15 Oct 2024 | 15.76% | 19.82 | |
| 31 Oct 2024 | 15.90% | 39.53 | |
| 15 Nov 2024 | 17.06% | 15.92 | |
| 29 Nov 2024 | 16.80% | 15.23 | |
| 13 Dec 2024 | 14.53% | 23.31 | 10-Q filed, results (8-K) |
| 31 Dec 2024 | 15.07% | 16.55 |
See also: KalVista Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.